Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fuji Nihon Seito Corporation is a Japanese company primarily known for sugar manufacturing that has diversified significantly into the life sciences and functional food sectors. The company's Life Science business focuses on the production and sale of functional ingredients such as inulin, a prebiotic fiber, and various cyclodextrins used in food, pharmaceuticals, and cosmetics. They also provide specialized fertilizers and food additives designed to improve health outcomes and food quality. Headquartered in Tokyo, Fuji Nihon Seito leverages its expertise in carbohydrate chemistry to develop innovative solutions for the global nutrition and wellness markets. The company is publicly traded on the Tokyo Stock Exchange and operates manufacturing facilities in both Japan and Thailand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fuji Nihon.